• First study assessing CMV seroprevalence among pregnant women in Lebanon. • Found intermediate-to-high IgG seroprevalence (71.2%) with low IgM prevalence (0.9%). • No significant associations with maternal age, obstetric history, or residence. • Results align Lebanon with Mediterranean countries in CMV epidemiology. • Provides baseline data to guide prevention and inform national health strategies. Cytomegalovirus (CMV) infection is a major global public health concern, particularly during pregnancy, due to its high seroprevalence and the risk of vertical transmission, leading to congenital infection and serious fetal complications. In Lebanon, data on CMV seroprevalence among pregnant women remains limited. This study aims to determine the seroprevalence of CMV among pregnant women in Lebanon and to explore associations with factors such as age, region of residence, and obstetric history. This retrospective observational study was conducted at Hôtel-Dieu de France Hospital in Beirut, Lebanon, between 2022 and 2024. Among 2,100 pregnant women followed during this period, 448 who underwent targeted serological screening for CMV immunity were included. Serological testing (IgG and IgM) was performed at the hospital laboratory using an enzyme-linked immunosorbent assay (ELISA) technique. Demographic and obstetric data, including age, region of residence, and obstetric history, were analyzed in relation to their serological status. Statistical significance was set at p 0.05). This study, the first of its kind in Lebanon, reveals an intermediate-to-high CMV seroprevalence among pregnant women, consistent with other Mediterranean populations. The absence of significant association between seropositivity and certain demographic and obstetric variables may reflect socio-economic and geographic homogeneity within the studied cohort.
Hachem et al. (Wed,) studied this question.